Note: Ingredients listed on restricted chemical lists
EC/CAS
108-95-2
Name of the chemical
Phenol
Concentration
N/A
EC/CAS
1314-13-2
Name of the chemical
Zinc oxide; C.I. 77947
Concentration
N/A
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Revision date
2005-02-15
Product name
Insulin (human), 28B-L-lysine-29B-L-proline-
Product Synonyms
Insulin, Lispro
Chemical name
Insulin (human), 28B-L-lysine-29B-L-proline-
Icons in SDS
Company Information
company name
Eli Lilly and Company
Section 2
SECTION 2: Hazards identification
Appearance: Clear solution Physical State: Liquid Odor: Odorless Emergency Overview Emergency Overview Effective Date: 10-Aug-1996 Lilly Laboratory Labeling Codes: Health 0 Fire 0 Reactivity 0 Primary Physical and Health Hazards: Not Considered a Health Hazard. Caution Statement: Insulin, Lispro is not considered to be a health hazard.
Principle Routes of Exposure
Inhalation and skin contact Effects of Overexposure: Dilute solutions do not pose a health hazard through typical routes of occupational exposure.
Medical Conditions Generally Aggravated by Exposure
Hypersensitivity to insulin Carcinogenicity: Insulin, lispro crystals - Not listed by IARC, NTP, ACGIH, or OSHA. One-year subcutaneous injection studies demonstrated no evidence of carcinogenicity in rats. Glycerin - Not listed by IARC, NTP, ACGIH, or OSHA. Two-year dietary studies demonstrated no evidence of carcinogenicity in rats. m-Cresol - Not listed by IARC, NTP, ACGIH, or OSHA. Two- to three-month dermal application studies with cresols demonstrated evidence of tumor promotion in mice. The relevance of these findings to humans is unknown. Remaining ingredients - Not listed by IARC, NTP, ACGIH, or OSHA.
